secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001493152-24-047420
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences receives Nasdaq delisting notice on Nov 20 for bid price failure
--------------------------------------------------------------------------------

- Nasdaq notified Enveric on Nov 20, 2024, that it failed to meet the $1.00 minimum bid price requirement by the Nov 12 compliance deadline.
- Company not eligible for a second 180-day extension due to insufficient stockholders' equity (below $5M initial listing requirement).
- Enveric intends to appeal and request a hearing before the Nasdaq Listing Qualifications Panel.
- Appeal stays delisting and trading suspension pending Panel decision; no guarantee of favorable outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315224047420/0001493152-24-047420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315224047420/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer